Antibody Drug Conjugates Contract Manufacturing Market is expected to expand at a CAGR of 12.3% from 2021 to 2028
Antibody Drug Conjugates Contract Manufacturing Industry Overview The global antibody drug conjugates contract manufacturing market size is anticipated to reach USD 18.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.3% from 2021 to 2028. The factors driving market expansion is complex nature of Antibody Drug Conjugates (ADCs), increasing demand for manufacturing capacity as well as increasing number of research on antibody therapies. Antibody Drug Conjugates Contract Manufacturing Market Segmentation Grand View Research has segmented the global antibody drug conjugates contract manufacturing market on the basis of condition, linker, and region: Based on the Condition Insights, the market is segmented into Myeloma, Lymphoma, Breast Cancer, and Others (Urothelial Cancer) The myeloma segment dominated the market and accounted for the largest revenue share of 49.4% in 2020. The factor...